Cargando…
Establishment of a bioluminescent canine B-cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studies
Canine diffuse large B-cell lymphoma (DLBCL) is one of the most common cancers in dogs which shares remarkable similarities with its human counterpart, making the dog an excellent model for the investigation of novel therapeutic agents. However, the integration of canine lymphoma in comparative stud...
Autores principales: | Dias, Joana N. R., André, Ana S., Aguiar, Sandra I., Ministro, Joana, Oliveira, Joana, Peleteiro, Maria C., Rütgen, Barbara, Gano, Lurdes, Correia, João D. G., Oliveira, Soraia S., Goncalves, Joao, Gil, Solange, Tavares, Luís, Aires-da-Silva, Frederico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310248/ https://www.ncbi.nlm.nih.gov/pubmed/30592723 http://dx.doi.org/10.1371/journal.pone.0208147 |
Ejemplares similares
-
The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma
por: Dias, Joana N.R., et al.
Publicado: (2018) -
Rabbit derived VL single-domains as promising scaffolds to generate antibody–drug conjugates
por: André, Ana S., et al.
Publicado: (2023) -
Panobinostat-loaded folate targeted liposomes as a promising drug delivery system for treatment of canine B-cell lymphoma
por: André, Ana S., et al.
Publicado: (2023) -
Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapy
por: Dias, Joana N. R., et al.
Publicado: (2022) -
Immunotherapeutic Strategies for Canine Lymphoma: Changing the Odds Against Non-Hodgkin Lymphoma
por: Dias, Joana N. R., et al.
Publicado: (2021)